At-home Drug of Abuse Testing Market Size & Share 2023 to 2032
Market Size by Type (Test Cups, Test Strips), by Sample Type (Saliva, Urine.
Report ID: GMI6485
|
Published Date: August 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Pratiksha Kamthe
At-home Drug of Abuse (DOA) Testing Market Size
At-Home Drug of Abuse Testing Market size was valued at USD 3.5 billion in 2022 and is estimated to register around 7% CAGR between 2023 and 2032. increasing production of illicit drugs will drive market growth.
At-home Drug of Abuse Testing Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
As the prevalence of cannabis use and other illicit drugs emphasizes the need for effective preventive measures and early interventions will lead to elevated demand for drug of abuse testing. Furthermore, governments and public health authorities worldwide have been implementing various initiatives to combat drug abuse and its related consequences. These initiatives include awareness campaigns, treatment programs, and drug testing programs in workplaces and schools. The increased emphasis on drug testing has further propelled the adoption of at-home drug of abuse (DOA) testing kits as an effective tool to support these efforts.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the at-home drug of abuse testing market due to increased drug consumption during lockdown. The increase in consumption volumes was attributed to higher frequencies and quantities of cannabis use, with herbal cannabis being a significant contributor to this trend. This raised concerns about illicit drug abuse, leading to higher demand for at-home drug of abuse (DOA) testing kits. These kits offered a convenient and confidential way for individuals to monitor their drug use and seek timely support.
Growing adoption of telemedicine and virtual consultations during the pandemic further supported the integration of at-home drug of abuse (DOA) testing into remote healthcare services. Moreover, innovations in testing technology also improved the accuracy and ease of use of at-home drug of abuse (DOA) testing kits. As the pandemic situation evolved, the at-home DOA testing market continued to grow to meet the demands of individuals seeking proactive and confidential means to monitor their drug use.
At-Home Drug of Abuse Testing Market Trends
Advancements in diagnostic technologies have led to significant improvements in the accuracy, sensitivity, and user-friendliness of at-home drug testing kits. Manufacturers have introduced innovative testing methods, such as rapid lateral flow tests and point-of-care molecular tests, which deliver quick and reliable results. Industry participants have expanded their product portfolios to encompass a broader range of drugs, including emerging synthetic drugs. This expansion enhances the relevance and utility of at-home drug testing kits, allowing individuals to monitor a wider spectrum of substances.
At-Home Drug of Abuse Testing Market Analysis
The test strips segment of at-home drug of abuse testing market surpassed USD 1.7 billion in 2022. Test strips offer quick and straightforward drug testing procedures, enabling individuals to monitor their drug use in the privacy of their homes. The rapid results provided by test strips facilitate instant feedback and timely decision-making. Despite, the widespread availability of test strips in physical stores and online platforms further contributes to their market dominance.
Furthermore, their versatility in detecting multiple drug classes, including opioids, cannabinoids, cocaine, and amphetamines, enhances their overall utility and appeal in addressing various drug screening needs. As the demand for at-home drug testing solutions continues to grow, test strips are anticipated to maintain their prominence as the preferred choice for proactive and reliable drug monitoring.
The urine segment held 38% share of the at-home drug of abuse testing market in 2022 and is poised to witness highest growth due to its practicality, ease of collection, and affordability. Urine-based testing offers a wide detection window, allowing it to detect a broad range of drugs and drug metabolites over an extended period, providing a comprehensive view of an individual's drug use history. The familiarity and acceptance of urine drug testing in various settings, along with the established regulatory framework and industry standards, contribute to its market dominance.
U.S. at-home drug of abuse testing market accounted for USD 1.2 billion in 2022 and is predicted to observe substantial growth. High prevalence of drug abuse and substance use disorders in the country has led to significant demand for drug testing solutions. Additionally, with a well-established healthcare infrastructure and regulatory support, at-home drug of abuse (DOA) testing kits is readily available and compliant with stringent standards, enhancing consumer trust. The rise of telehealth and remote monitoring in the U.S. has facilitated the integration of at-home drug of abuse (DOA) testing into virtual consultations, promoting their use.
An initiative-taking approach to healthcare, industry innovation, and diverse drug testing needs further contribute to the popularity and dominance of the U.S. market in meeting the growing demand for accessible and effective drug monitoring solutions.
At-home Drug of Abuse Testing Market Share
Some of the eminent market participants operating in the at-home drug of abuse testing market include :
These participants are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
At-home Drug of Abuse Testing Industry News:
This at-home drug of abuse testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Type
By Sample Type
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →